Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

p63 antibody (AA 540-680)

This anti-p63 antibody is a Mouse Monoclonal antibody detecting p63 in WB. Suitable for Human.
Catalog No. ABIN7629180

Quick Overview for p63 antibody (AA 540-680) (ABIN7629180)

Target

See all p63 (TP63) Antibodies
p63 (TP63) (Tumor Protein P63 (TP63))

Reactivity

  • 64
  • 25
  • 20
  • 5
  • 2
  • 2
Human

Host

  • 49
  • 22
  • 1
Mouse

Clonality

  • 42
  • 30
Monoclonal

Conjugate

  • 62
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This p63 antibody is un-conjugated

Application

  • 45
  • 30
  • 26
  • 14
  • 14
  • 10
  • 9
  • 9
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

D2
  • Binding Specificity

    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 540-680

    Purpose

    Tumor Protein P63 (TP63) Monoclonal Antibody

    Sequence

    Pro540~Glu680

    Characteristics

    The Tumor Protein P63 (TP63) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB.

    Purification

    Protein A + Protein G affinity chromatography

    Isotype

    IgG2b kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.63 mg/mL

    Buffer

    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    p63 (TP63) (Tumor Protein P63 (TP63))

    Alternative Name

    TP63

    Gene ID

    8626

    UniProt

    Q9H3D4
You are here:
Chat with us!